Enlivex (ENLV) Assets (2013 - 2025)
Enlivex (ENLV) posted quarterly Assets of $606.8 million for Q4 2025, up 2091.57% year-over-year from $27.7 million in Q4 2024, and up 2797.99% quarter-over-quarter from $20.9 million in Q3 2025.
Enlivex (ENLV) Assets (2013 - 2025) Analysis & Trends
Enlivex's Assets history runs 13 years deep, the most recent figure standing at $606.8 million for Q4 2025.
- In Q4 2025, Assets rose 2091.57% year-over-year to $606.8 million; the TTM figure through Dec 2025 stood at $606.8 million (up 2091.57% YoY), while the FY2025 annual figure was $606.8 million, up 2091.57% from the prior year.
- Assets for Q4 2025 stood at $606.8 million, up from $20.9 million in the prior quarter.
- The five-year high for Assets was $606.8 million in Q4 2025, with the low at $20.9 million in Q3 2025.
- The 5-year median for Assets is $56.5 million (2023), against an average of $84.1 million.
- The sharpest annual moves came in 2024 and 2025: Assets tumbled 48.27% in 2024, then surged 2091.57% in 2025.
- Enlivex's Assets stood at $95.1 million in 2021, then retreated by 28.91% to $67.6 million in 2022, then sank by 45.55% to $36.8 million in 2023, then retreated by 24.83% to $27.7 million in 2024, then soared by 2091.57% to $606.8 million in 2025.
- Business Quant data shows ENLV's Assets at $606.8 million in Q4 2025, $20.9 million in Q3 2025, and $22.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 19.82 Bn |
| 10 | Enlivex | 4.51 Mn | -1.25 Mn | - | 606.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 606.78 Mn |
| Sep 30, 2025 | 20.94 Mn |
| Jun 30, 2025 | 22.60 Mn |
| Mar 31, 2025 | 24.04 Mn |
| Dec 31, 2024 | 27.69 Mn |
| Sep 30, 2024 | 29.80 Mn |
| Jun 30, 2024 | 31.90 Mn |
| Mar 31, 2024 | 31.05 Mn |
| Dec 31, 2023 | 36.83 Mn |
| Sep 30, 2023 | 46.94 Mn |
| Jun 30, 2023 | 53.03 Mn |
| Mar 31, 2023 | 60.02 Mn |
| Dec 31, 2022 | 67.64 Mn |
| Sep 30, 2022 | 72.41 Mn |
| Jun 30, 2022 | 77.34 Mn |
| Mar 31, 2022 | 88.62 Mn |
| Dec 31, 2021 | 95.15 Mn |
| Sep 30, 2021 | 98.17 Mn |
| Jun 30, 2021 | 95.19 Mn |
| Mar 31, 2021 | 95.96 Mn |